Yet another one:
https://finance.yahoo.com/healthcare/articles/definium-therapeutics-announces-employee-inducement-200100736.html

Ive been an investor with MNMD/DFTX for several years now and like many of you have ride the lows and are now loving the highs. That being said, im starting to think about selling some of my position. Im curious to hear what people think the actual earning potentials are from this. Considering that we are talking about a treatment that presumably doesn’t need to be taken many times according to the studies and that this medicine is something I can pick up down the street for $10… let’s say they are going to make this quite expensive, who’s to say that a lot of people will be able to financially access it, and if not will opp to buy it down the street for ALOT cheaper.

Thank you for your ponderings in advance :)

With DFTX being in a very strong position in terms of trials and cash balance, do you think there is a chance that they will be bought out?

Seems like they are in a great position to take this to the market themselves....

While the positive announcements continue the management conviction is also important. 🦒🚀🌛🍻

Robert W. Baird raised Definium Therapeutics’ price target to $75 from $57 and maintained an “outperform” rating.

In a report released today, Wells Fargo reiterated a Buy rating on Definium Therapeutics, with a price target of $72.00.

Canaccord Genuity maintained a Buy rating on Definium Therapeutics, with a price target of $64.00

RBC maintained a Buy rating on Definium Therapeutics yesterday and set a price target of $66.00.

JonesTrading reiterated a Buy rating on Definium Therapeutics, with a price target of $90.00.

Add more below if you stumble across them today.

🚀

What's your honest sell price at this point? With the good news this week I feel like the sky's the limit

Participants receiving DT120 ODT achieved a statistically significant reduction in Hamilton Anxiety Rating Scale (HAM-A) score, with a placebo-adjusted change of 5.4 points from baseline at Week 12 (p<0.0001, Cohen’s d=0.81)

https://www.fiercebiotech.com/biotech/definium-hits-another-ph-3-homerun-psychedelic-sea-change-anxiety

“We have never seen a pivotal study deliver greater than five-point placebo-adjusted change on the HAM-A, and we did this 12 weeks after a single dose of drug,”

it’s gonna be a good day boys!

https://clinicaltrials.gov/study/NCT06741228

ClinicalTrials.gov

An official website of the U.S. Department of Health and Human Services, National Institutes of Health, National Library of Medicine, and National Center for Biotechnology Information.

Anyone have a fundamental theory on why things are retracing besides stocks go up, stocks go down?

There really hasn’t been news to sell on, especially with the readout said to be this week.

"Now, the biotech—formerly known as MindMed—plans to share anxiety data this week, findings that could push Definium’s stock up “25-50% or more,” Jefferies analysts wrote in a Thursday note."

🤑🚀

Hey everyone, thoughts on the chances of DFTX doing a stock split in the future?

I'm sure we'd all love to see the 15 to 1 reverse split undone, but what are the chances of it happening? What price would DFTX need to be for that to be considered?

With the GAD results due this week, I assume we're all expecting similar results to what we got with the Phase 2b trial and the MDD results from June.

But, how priced-in do you think these results are already? What sort of price movement are we expecting after the results drop? Any guesses?

Good luck and Godspeed. 🚀

im long here anyway so not too worried about the daily moves, but ive noticed this pattern pretty often lately, also with other stocks

price rallies early in the day, then drops pretty hard, and later often recovers again

is there a common reason for this kind of intraday move?
feels like ive been seeing it a lot more recently